Targeting the Gremlin–VEGFR2 axis – a promising strategy for multiple diseases?

E-ISSN： 1555-2039|236|4|403-406

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.236, Iss.4, 2015-08, pp. : 403-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis of 4‐Anilinoquinazoline‐Derivative Dual Kinase Inhibitors Targeting EGFR and VEGFR‐2

BULLETIN OF THE KOREAN CHEMICAL SOCIETY (ELECTRONIC), Vol. 39, Iss. 1, 2018-01 ,pp. : 123-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti‐angiogenic activity of thienopyridine derivative LCB03‐0110 by targeting VEGFR‐2 and JAK/STAT3 Signalling

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 7, 2015-07 ,pp. : 503-509

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting the T Helper 2 Inflammatory Axis in Atopic Dermatitis

International Archives of Allergy and Immunology, Vol. 171, Iss. 2, 2016-11 ,pp. : 71-80

Karger

Access to resources Recommend Favorite

Targeting Neurogenesis: A Promising Therapeutic Strategy for Post-Stroke Treatment with Chinese Herbal Medicine

Integrative Medicine International, Vol. 1, Iss. 1, 2014-05 ,pp. : 5-18

Karger

Access to resources Recommend Favorite

Synergistic inhibition of cell proliferation by combined targeting with kinase inhibitors and dietary xanthone is a promising strategy for melanoma treatment

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 43, Iss. 2, 2018-03 ,pp. : 149-157

John Wiley & Sons Inc

Access to resources Recommend Favorite